These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 24088953)
1. The Nrf2 triterpenoid activator, CDDO-imidazolide, protects kidneys from ischemia-reperfusion injury in mice. Liu M; Reddy NM; Higbee EM; Potteti HR; Noel S; Racusen L; Kensler TW; Sporn MB; Reddy SP; Rabb H Kidney Int; 2014 Jan; 85(1):134-41. PubMed ID: 24088953 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion. Xu Z; Cho H; Hartsock MJ; Mitchell KL; Gong J; Wu L; Wei Y; Wang S; Thimmulappa RK; Sporn MB; Biswal S; Welsbie DS; Duh EJ J Neurochem; 2015 Apr; 133(2):233-41. PubMed ID: 25683606 [TBL] [Abstract][Full Text] [Related]
3. The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy. Xu D; Chen L; Chen X; Wen Y; Yu C; Yao J; Wu H; Wang X; Xia Q; Kong X Cell Death Dis; 2017 Aug; 8(8):e2983. PubMed ID: 28796242 [TBL] [Abstract][Full Text] [Related]
4. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Shin S; Wakabayashi J; Yates MS; Wakabayashi N; Dolan PM; Aja S; Liby KT; Sporn MB; Yamamoto M; Kensler TW Eur J Pharmacol; 2009 Oct; 620(1-3):138-44. PubMed ID: 19698707 [TBL] [Abstract][Full Text] [Related]
5. The triterpenoid CDDO-imidazolide confers potent protection against hyperoxic acute lung injury in mice. Reddy NM; Suryanaraya V; Yates MS; Kleeberger SR; Hassoun PM; Yamamoto M; Liby KT; Sporn MB; Kensler TW; Reddy SP Am J Respir Crit Care Med; 2009 Nov; 180(9):867-74. PubMed ID: 19679692 [TBL] [Abstract][Full Text] [Related]
6. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis. To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751 [TBL] [Abstract][Full Text] [Related]
7. CDDO-Im exerts antidepressant-like effects via the Nrf2/ARE pathway in a rat model of post-stroke depression. Hou X; Liu H; Ping Y; Zhang F; Zhi L; Jiang X; Zhang F; Song C; Zhang Z; Song J Brain Res Bull; 2021 Aug; 173():74-81. PubMed ID: 33991607 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation. Zagorski JW; Turley AE; Freeborn RA; VanDenBerg KR; Dover HE; Kardell BR; Liby KT; Rockwell CE Biochem Pharmacol; 2018 Jan; 147():67-76. PubMed ID: 29155145 [TBL] [Abstract][Full Text] [Related]
9. The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling. Liby K; Hock T; Yore MM; Suh N; Place AE; Risingsong R; Williams CR; Royce DB; Honda T; Honda Y; Gribble GW; Hill-Kapturczak N; Agarwal A; Sporn MB Cancer Res; 2005 Jun; 65(11):4789-98. PubMed ID: 15930299 [TBL] [Abstract][Full Text] [Related]
10. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes. Reisman SA; Buckley DB; Tanaka Y; Klaassen CD Toxicol Appl Pharmacol; 2009 Apr; 236(1):109-14. PubMed ID: 19371629 [TBL] [Abstract][Full Text] [Related]
11. Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide. Thimmulappa RK; Scollick C; Traore K; Yates M; Trush MA; Liby KT; Sporn MB; Yamamoto M; Kensler TW; Biswal S Biochem Biophys Res Commun; 2006 Dec; 351(4):883-9. PubMed ID: 17097057 [TBL] [Abstract][Full Text] [Related]
12. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice. Osburn WO; Yates MS; Dolan PD; Chen S; Liby KT; Sporn MB; Taguchi K; Yamamoto M; Kensler TW Toxicol Sci; 2008 Jul; 104(1):218-27. PubMed ID: 18417483 [TBL] [Abstract][Full Text] [Related]
13. RTA-408 Protects Kidney from Ischemia-Reperfusion Injury in Mice via Activating Nrf2 and Downstream GSH Biosynthesis Gene. Han P; Qin Z; Tang J; Xu Z; Li R; Jiang X; Yang C; Xing Q; Qi X; Tang M; Zhang J; Shen B; Wang W; Qin C; Zhang W Oxid Med Cell Longev; 2017; 2017():7612182. PubMed ID: 29435098 [TBL] [Abstract][Full Text] [Related]
14. Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Liu M; Grigoryev DN; Crow MT; Haas M; Yamamoto M; Reddy SP; Rabb H Kidney Int; 2009 Aug; 76(3):277-85. PubMed ID: 19436334 [TBL] [Abstract][Full Text] [Related]
15. Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARĪ³, and HO-1. Wu QQ; Wang Y; Senitko M; Meyer C; Wigley WC; Ferguson DA; Grossman E; Chen J; Zhou XJ; Hartono J; Winterberg P; Chen B; Agarwal A; Lu CY Am J Physiol Renal Physiol; 2011 May; 300(5):F1180-92. PubMed ID: 21289052 [TBL] [Abstract][Full Text] [Related]
16. Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Sussan TE; Rangasamy T; Blake DJ; Malhotra D; El-Haddad H; Bedja D; Yates MS; Kombairaju P; Yamamoto M; Liby KT; Sporn MB; Gabrielson KL; Champion HC; Tuder RM; Kensler TW; Biswal S Proc Natl Acad Sci U S A; 2009 Jan; 106(1):250-5. PubMed ID: 19104057 [TBL] [Abstract][Full Text] [Related]
17. Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN. Pitha-Rowe I; Liby K; Royce D; Sporn M Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5339-47. PubMed ID: 19494206 [TBL] [Abstract][Full Text] [Related]
18. The Role of Nrf2 in D-Galactose-Induced Cardiac Aging in Mice: Involvement of Oxidative Stress. Yang X; Jia J; Ding L; Yu Z; Qu C Gerontology; 2021; 67(1):91-100. PubMed ID: 33271531 [TBL] [Abstract][Full Text] [Related]
19. A Point Mutation at C151 of Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495 [TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils. Thimmulappa RK; Fuchs RJ; Malhotra D; Scollick C; Traore K; Bream JH; Trush MA; Liby KT; Sporn MB; Kensler TW; Biswal S Antioxid Redox Signal; 2007 Nov; 9(11):1963-70. PubMed ID: 17822364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]